The U.S. Agency for International Development (USAID) launched the Supporting, Mobilizing, and Accelerating Research for Tuberculosis Elimination (SMART4TB) project. SMART4TB, a five-year initiative, will invest up to $200 million, subject to availability of funding, to identify more effective methods and tools for finding, treating, and preventing tuberculosis (TB) in USAID’s 24 priority countries for TB programming.
This initiative will build research capacity in high TB burden countries by supporting studies that evaluate novel approaches, interventions, and tools to combat TB–including diagnostic tests, new treatment drugs and regimens, socioeconomic and health system challenges, methods to interrupt TB transmission, and TB vaccines readiness and delivery.
Led by Johns Hopkins University School of Medicine, the SMART4TB international consortium partners are University of California, San Francisco, KNCV Tuberculosis Foundation, Elizabeth Glaser Pediatric AIDS Foundation, Treatment Action Group, Perinatal HIV Research Unit (South Africa), YR Gaitonde Medical, Educational and Research Foundation (India), Walimu (Uganda), Kyrgyz State Medical Academy, and Victory Network (Vietnam).
As the world’s largest bilateral donor leading the fight to end TB, USAID is committed to helping countries reach the TB Sustainable Development Goals by 2030 to end TB globally. Since 2000, USAID and partners’ TB efforts have saved more than 66 million lives. Learn more about USAID’s TB work here.